Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Cash Flow Reinvestment Rate
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow Reinvestment Rate of 0.64x as of September 2025, reinvesting CN¥128.94 Million (capex CN¥128.94 Million ) from operating cash flow of CN¥201.83 Million. Explore 600557 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2001–2024)
Historical reinvestment intensity for Jiangsu Kanion Pharmaceutical Co Ltd across 23 annual periods. Also explore total assets of Jiangsu Kanion Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year capital reinvestment analysis for Jiangsu Kanion Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Jiangsu Kanion Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.31x | CN¥919.25 Million | CN¥702.49 Million | CN¥476.69 Million | ▲ +51.9% |
| 2023 | 0.86x | CN¥837.79 Million | CN¥972.32 Million | CN¥297.48 Million | ▲ +269.6% |
| 2022 | 0.23x | CN¥232.16 Million | CN¥995.94 Million | CN¥211.09 Million | ▼ -35.8% |
| 2021 | 0.36x | CN¥330.02 Million | CN¥908.30 Million | CN¥171.52 Million | ▼ -12.1% |
| 2020 | 0.41x | CN¥289.74 Million | CN¥701.10 Million | CN¥190.32 Million | ▼ -22.1% |
| 2019 | 0.53x | CN¥491.24 Million | CN¥925.73 Million | CN¥490.06 Million | ▲ +3.6% |
| 2018 | 0.51x | CN¥325.92 Million | CN¥636.39 Million | CN¥315.73 Million | ▼ -49.5% |
| 2017 | 1.01x | CN¥388.01 Million | CN¥382.93 Million | CN¥260.94 Million | ▼ -10.0% |
| 2016 | 1.13x | CN¥336.59 Million | CN¥299.02 Million | CN¥325.24 Million | ▲ +50.1% |
| 2015 | 0.75x | CN¥386.09 Million | CN¥514.80 Million | CN¥374.80 Million | ▼ -24.5% |
| 2014 | 0.99x | CN¥309.36 Million | CN¥311.54 Million | CN¥309.36 Million | ▲ +13.6% |
| 2013 | 0.87x | CN¥339.23 Million | CN¥388.11 Million | CN¥339.23 Million | ▼ -27.0% |
| 2012 | 1.20x | CN¥253.88 Million | CN¥212.11 Million | CN¥253.88 Million | ▼ -63.2% |
| 2011 | 3.25x | CN¥293.53 Million | CN¥90.19 Million | CN¥293.53 Million | ▲ +90.1% |
| 2010 | 1.71x | CN¥284.89 Million | CN¥166.40 Million | CN¥284.89 Million | ▲ +15.3% |
| 2008 | 1.48x | CN¥86.69 Million | CN¥58.39 Million | CN¥86.69 Million | ▲ +133.8% |
| 2007 | 0.63x | CN¥58.88 Million | CN¥92.73 Million | CN¥58.88 Million | ▲ +182.2% |
| 2006 | 0.22x | CN¥24.52 Million | CN¥108.98 Million | CN¥24.52 Million | ▼ -57.3% |
| 2005 | 0.53x | CN¥53.39 Million | CN¥101.44 Million | CN¥53.39 Million | ▼ -90.7% |
| 2004 | 5.66x | CN¥122.68 Million | CN¥21.68 Million | CN¥122.68 Million | ▼ -23.5% |
| 2003 | 7.40x | CN¥126.72 Million | CN¥17.13 Million | CN¥126.72 Million | ▼ -6.3% |
| 2002 | 7.90x | CN¥88.07 Million | CN¥11.15 Million | CN¥88.07 Million | ▲ +800.5% |
| 2001 | 0.88x | CN¥18.43 Million | CN¥21.02 Million | CN¥18.43 Million | — |